-
- 抗原 See all TAZ 抗体
- TAZ (Tafazzin (TAZ))
-
抗原表位
- AA 174-248
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This TAZ antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 序列
- NDVLPNSPPY FPRFGQKITV LIGKPFSALP VLERLRAENK SAVEMRKALT DFIQEEFQHL KTQAEQLHNH LQPGR
- 交叉反应
- 人, 小鼠, 大鼠
- 产品特性
- Polyclonal Antibodies
- 免疫原
- Recombinant fusion protein containing a sequence corresponding to amino acids 174-248 of human Tafazzin / TAZ (NP_851830.1).
- 亚型
- IgG
- Top Product
- Discover our top product TAZ Primary Antibody
-
anti-Tafazzin (TAZ) (AA 1-262) antibody
TAZ 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 1B10 unconjugated
anti-Tafazzin (TAZ) (AA 32-60) antibodyTAZ 适用: 人 WB, ELISA, IHC, FACS 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 1-100) antibodyTAZ 适用: 人, 小鼠, 大鼠 WB, ELISA, IF (cc), IF (p), FACS, ICC, IHC (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 46-240) antibodyTAZ 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 95-262) antibodyTAZ 适用: 人 ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 154-292) antibodyTAZ 适用: 人 WB, IHC, ICC 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 32-60), (N-Term) antibodyTAZ 适用: 人 WB, FACS, IHC (p) 宿主: 兔 Polyclonal RB21836 unconjugated
anti-Tafazzin (TAZ) (AA 1-262) antibodyTAZ 适用: 人 ELISA, IF 宿主: 小鼠 Monoclonal 3C10 unconjugated
anti-Tafazzin (TAZ) (AA 46-239) antibodyTAZ 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 192-241) antibodyTAZ 适用: 人, 小鼠, 大鼠, 犬, Cow, 兔, Bat, 猴 WB 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- WB,1:1000 - 1:2000
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C. Avoid freeze / thaw cycles.
-
- 抗原
- TAZ (Tafazzin (TAZ))
- 别名
- TAZ (TAZ 产品)
- 背景
- This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.,TAZ,BTHS,CMD3A,EFE,EFE2,G4.5,LVNCX,Taz1,tafazzin,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,TAZ
- 分子量
- 25 kDa/27 kDa/28 kDa/29 kDa/30 kDa/31 kDa/33 kDa
- 基因ID
- 6901
- UniProt
- Q16635
-
You are here:
